GEN Exclusives

More »

GEN News Highlights

More »
Feb 15, 2007

Abraxis Completes Acquisition of Pfizer Manufacturing Complex

  • Abraxis BioScienc finalized the acquisition of the Pfizer Cruce Dávila manufacturing facility in Barceloneta, Puerto Rico. This 56-acre site consists of a 172,000-sq-ft plant with capabilities of producing injectable pharmaceuticals as well as protein-based biologics and metered-dosed inhalers, according to Abraxis.

    In addition, the acquisition includes a computer-controlled 90,000-sq-ft active pharmaceutical ingredients manufacturing plant and two support facilities with quality assurance and laboratories.

    Under the terms of the agreement, Abraxis will lease the active pharmaceuticals ingredients plant back to Pfizer. Abraxis expects to begin commercial manufacturing from this site in the first half of 2007.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?